GlassScriptPhysician profile
Gerald Anthony Meis
NPI 1801859947
$3,127.36
in general payments reported to CMS, 2019-2025
21 companies · $411 in 2025
The $411 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $47.84 · 2020: $118 · 2021: $267 · 2022: $689 · 2023: $1,018 · 2024: $577 · 2025: $411.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,926 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,925.51 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $729.93 | 2019-2025 | Breztri, Fasenra, Tezspire |
| Genzyme Corporation | $720.01 | 2021-2025 | |
| Philips North America LLC | $458.63 | 2021-2025 | (Ak6) Vest Therapy, Vest Therapy Und |
| Jazz Pharmaceuticals INC. | $246.15 | 2023 | Xywav |
| Glaxosmithkline, LLC. | $185.60 | 2022-2025 | Trelegy Ellipta, Nucala, Shingrix |
| Advanced Respiratory, INC | $175.33 | 2020-2021 | |
| Verona Pharma, INC. | $93.07 | 2025 | Ohtuvayre |
| Sanofi-Aventis U.S. LLC | $79.99 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $68.68 | 2021-2023 | Dupixent |
| Novartis Pharmaceuticals Corporation | $57.39 | 2022-2023 | |
| Misonix INC | $42.69 | 2021 | |
| Mylan Specialty L.P. | $40.63 | 2022-2024 | Yupelri |
| Ani Pharmaceuticals, INC. | $34.26 | 2023-2024 | Purified Cortrophin Gel |
| Baxter Healthcare | $30.82 | 2024 | Hillrom - Vest System Model 105 Home Care |
| Vapotherm INC | $29.00 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $27.96 | 2025 | Inspire |
| Inogen, INC. | $27.91 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Amgen INC. | $24.04 | 2021 | |
| United Therapeutics Corporation | $20.65 | 2021 | |
| Insmed, INC. | $20.06 | 2024 | Arikayce |
| Genentech USA, INC. | $14.56 | 2024 | Xolair |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gerald Meis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.